• Je něco špatně v tomto záznamu ?

Interaction of GABAA and GABAB antagonists after status epilepticus in immature rats

P. Mareš, H. Kubová,

. 2020 ; 102 (-) : 106683. [pub] 20191121

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028634

Among neurotransmitter systems affected by status epilepticus (SE) in adult rats are both GABAergic systems. To analyze possible changes of GABAA and GABAB systems in developing rats lithium-pilocarpine SE was induced at postnatal day 12 (P12). Seizures were elicited by a GABAA antagonist pentylenetetrazol (PTZ) 3, 6, 9, and 13 days after SE (i.e., in P15, P18, P21, and P25 rats), and their possible potentiation by a GABAB receptor antagonist CGP46381 was studied. Pilocarpine was replaced by saline in control animals (lithium-paraldehyde [LiPAR]). Pentylenetetrazol in a dose of 50 mg/kg s.c. elicited generalized seizures in nearly all 15-day-old naive rats and in 40% of 18-day-old ones but not in older animals. After SE, PTZ no longer elicited seizures in these two younger groups, i.e., sensitivity of GABAA system was diminished. The GABAB antagonist exhibited proconvulsant effect in P15 and P18 SE as well as LiPAR rats returning the incidence of PTZ-induced seizures to values of control animals. A decrease in the incidence of minimal clonic seizures was seen in P21 LiPAR animals; these seizures in the oldest group were not affected. Change of the effect from proconvulsant to anticonvulsant (or at least to no action) took place before postnatal day 21. Both SE and LiPAR animals exhibited similar changes but their intensity differed, effects in LiPAR controls were usually more expressed than in SE rats.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028634
003      
CZ-PrNML
005      
20210114154523.0
007      
ta
008      
210105s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.yebeh.2019.106683 $2 doi
035    __
$a (PubMed)31760199
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Mareš, Pavel $u Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: Pavel.Mares@fgu.cas.cz.
245    10
$a Interaction of GABAA and GABAB antagonists after status epilepticus in immature rats / $c P. Mareš, H. Kubová,
520    9_
$a Among neurotransmitter systems affected by status epilepticus (SE) in adult rats are both GABAergic systems. To analyze possible changes of GABAA and GABAB systems in developing rats lithium-pilocarpine SE was induced at postnatal day 12 (P12). Seizures were elicited by a GABAA antagonist pentylenetetrazol (PTZ) 3, 6, 9, and 13 days after SE (i.e., in P15, P18, P21, and P25 rats), and their possible potentiation by a GABAB receptor antagonist CGP46381 was studied. Pilocarpine was replaced by saline in control animals (lithium-paraldehyde [LiPAR]). Pentylenetetrazol in a dose of 50 mg/kg s.c. elicited generalized seizures in nearly all 15-day-old naive rats and in 40% of 18-day-old ones but not in older animals. After SE, PTZ no longer elicited seizures in these two younger groups, i.e., sensitivity of GABAA system was diminished. The GABAB antagonist exhibited proconvulsant effect in P15 and P18 SE as well as LiPAR rats returning the incidence of PTZ-induced seizures to values of control animals. A decrease in the incidence of minimal clonic seizures was seen in P21 LiPAR animals; these seizures in the oldest group were not affected. Change of the effect from proconvulsant to anticonvulsant (or at least to no action) took place before postnatal day 21. Both SE and LiPAR animals exhibited similar changes but their intensity differed, effects in LiPAR controls were usually more expressed than in SE rats.
650    _2
$a zvířata $7 D000818
650    _2
$a novorozená zvířata $7 D000831
650    _2
$a antikonvulziva $x terapeutické užití $7 D000927
650    _2
$a lékové interakce $x fyziologie $7 D004347
650    _2
$a antagonisté receptorů GABA-A $x metabolismus $7 D058787
650    _2
$a antagonisté receptorů GABA-B $x škodlivé účinky $x metabolismus $7 D058788
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a pentylentetrazol $x škodlivé účinky $7 D010433
650    _2
$a kyseliny fosfinové $x škodlivé účinky $x metabolismus $7 D010721
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a status epilepticus $x chemicky indukované $x farmakoterapie $x metabolismus $7 D013226
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kubová, Hana $u Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: Hana.Kubova@fgu.cas.cz.
773    0_
$w MED00005701 $t Epilepsy & behavior : E&B $x 1525-5069 $g Roč. 102, č. - (2020), s. 106683
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31760199 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154520 $b ABA008
999    __
$a ok $b bmc $g 1608969 $s 1119814
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 102 $c - $d 106683 $e 20191121 $i 1525-5069 $m Epilepsy & behavior $n Epilepsy Behav $x MED00005701
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...